Molecular studies investigating PCa mortality and metastatic progression have suggested that the Akt–PI3K-pathway activation phosphorylates GSK-3α and/or inhibits GSK-3β activity [31–33]. This evidence concerns the gene GSK3A and posterior cortical atrophy.